Orbus Therapeutics primary focus is development and commercialization of therapeutic products that treat patients suffering from rare diseases for which there are few available effective therapies.

To unlock the greatest value for patients and investors, we are actively seeking corporate partners to help us to develop and commercialize our lead product candidate, eflornithine.

Our strategy is to sell and market products in North America, and we continue to evaluate additional development stage and commercial stage opportunities to add to our portfolio.

Strategic partners interested in obtaining additional information about our product candidate and our company, please email us directly at info@orbustherapeutics.com.